Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease

被引:27
|
作者
Kan, Hiromi [1 ]
Kimura, Yuki [3 ]
Hyogo, Hideyuki [1 ]
Fukuhara, Takayuki [1 ]
Fujino, Hatsue [1 ]
Naeshiro, Noriaki [1 ]
Honda, Yohji [1 ]
Kawaoka, Tomokazu [1 ]
Tsuge, Masataka [1 ]
Hiramatsu, Akira [1 ]
Imamura, Michio [1 ]
Kawakami, Yoshiiku [1 ]
Aikata, Hiroshi [1 ]
Ochi, Hidenori [1 ]
Arihiro, Koji [2 ]
Chayama, Kazuaki [1 ]
机构
[1] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan
[2] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima 7348551, Japan
[3] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Preven, Hiroshima, Japan
关键词
liver to spleen ratio; non-alcoholic fatty liver disease; non-invasive assessment; steatotic grade; COMPUTED-TOMOGRAPHY; INSULIN-RESISTANCE; STEATOHEPATITIS; PREVALENCE; UTILITY; DONORS; COMMON; CT;
D O I
10.1111/hepr.12330
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimThe diagnosis of non-alcoholic fatty liver disease (NAFLD) is based on the histological findings. Further, there may be interobserver differences. Liver to spleen (L/S) ratio on computed tomography (CT) is employed to detect or even quantify the fat content of the liver. The objective of this study was to accurately diagnose fatty liver by evaluating the relationship between L/S ratio and histological findings. MethodsSixty-seven biopsy-proven NAFLD patients were enrolled. L/S ratio on CT was calculated. The area of steatosis in liver specimens was measured by BIOREVO BZ-9000 microscope, and the percentage of steatosis was calculated using Dynamic cell count BZ-H1C software. ResultsSteatotic grade assessed by pathologist was significantly correlated with the percentage of steatosis and L/S ratio. Factors associated with steatosis were L/S ratio, aspartate aminotransferase and Homeostasis Model of Assessment - Insulin Resistance as determined by multivariate analysis. L/S ratios were: S0, 1.160.20 (mean +/- standard deviation); S1, 0.88 +/- 0.28; S2, 0.76 +/- 0.20; and S3, 0.40 +/- 0.18, respectively. The optimal cut-off value of L/S ratio to exclude steatosis was 1.1, and the area under the receiver-operator curve for the diagnosis of steatosis was 0.886. ConclusionOur study suggests that while 0% of steatosis showed 1.296 L/S ratio, the cut-off value of L/S ratio would be 1.1 at least to exclude clinically important liver steatosis.
引用
收藏
页码:E420 / E427
页数:8
相关论文
共 50 条
  • [1] Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease
    Chen, Bryan R.
    Pan, Calvin Q.
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (01)
  • [2] Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
    Rios, Rafael S.
    Zheng, Kenneth I.
    Targher, Giovanni
    Byrne, Christopher D.
    Zheng, Ming-Hua
    [J]. CHINESE MEDICAL JOURNAL, 2020, 133 (22) : 2743 - 2745
  • [3] Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
    S. Rios Rafael
    I Zheng Kenneth
    Targher Giovanni
    Byrne Christopher D.
    Zheng Ming-Hua
    [J]. 中华医学杂志(英文版), 2020, 133 (22) : 2743 - 2745
  • [4] Non-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease
    Altamirano, Jose
    Qi, Qiaochu
    Choudhry, Sabina
    Abdallah, Mohamed
    Singal, Ashwani K.
    Humar, Abhinav
    Bataller, Ramon
    Borhani, Amir Ali
    Duarte-Rojo, Andres
    [J]. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [5] Non-Invasive Approaches to Estimate Liver Steatosis and Stiffness in Children With Non-Alcoholic Fatty Liver Disease
    Yodoshi, Toshifumi
    Orkin, Sarah
    Trout, Andrew T.
    Arce-Clachar, Ana Catalina
    Bramlage, Kristin
    Liu, Chunyan
    Fei, Lin
    Dillman, Jonathan R.
    Xanthakos, Stavra A.
    Mouzaki, Marialena
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 74 (04): : 495 - 502
  • [6] Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
    Alnimer, Lynna
    Noureddin, Mazen
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (02) : 394 - 397
  • [7] Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
    Nogami, Asako
    Yoneda, Masato
    Iwaki, Michihiro
    Kobayashi, Takashi
    Honda, Yasushi
    Ogawa, Yuji
    Imajo, Kento
    Saito, Satoru
    Nakajima, Atsushi
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 : S123 - S135
  • [8] NON-INVASIVE ASSESSMENT OF FIBROSIS PROGRESSION IN NON-ALCOHOLIC FATTY LIVER DISEASE
    Hanafy, A. S.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S473 - S473
  • [9] Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Vizzutti, Francesco
    Arena, Umberto
    Nobili, Valerio
    Tarquini, Roberto
    Trappoliere, Marco
    Laffi, Giacomo
    Marra, Fabio
    Pinzani, Massimo
    [J]. ANNALS OF HEPATOLOGY, 2009, 8 (02) : 89 - 94
  • [10] Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature
    Maida, M.
    Macaluso, F. S.
    Salomone, F.
    Petta, S.
    [J]. CURRENT MOLECULAR MEDICINE, 2016, 16 (08) : 721 - 737